Vitamin D binding protein variants and the risk of COPD

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 3 PART I, 1998, Pages 957-961

  Schellenberg, Devin ^a   Paré, Peter D ^a,b   Weir, Tracey D ^a   Spinelli, John J ^a   Walker, Blair A M ^a   Sandford, Andrew J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; VITAMIN D;

ALLELE; ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR;

AIRWAY RESISTANCE; ALLELES; ALPHA 1-ANTITRYPSIN DEFICIENCY; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C5A; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); ELASTICITY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; LUNG COMPLIANCE; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; NEUTROPHILS; ODDS RATIO; PHENOTYPE; RISK FACTORS; SMOKING; VARIATION (GENETICS); VITAMIN D-BINDING PROTEIN;

EID: 0031921469     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.3.9706106     Document Type: Article

References (27)

1. Fletcher, C., R. Peto, C. Tinker, and F. E. Speizer. 1976. The Natural History of Chronic Bronchitis: An Eight Year Follow-up Study of Working Men in London. Oxford University Press, Oxford.
2. Higgins, M., and J. Keller. 1975. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J. Chronic Dis. 28:239-251.
3. Tager, I. B., B. Rosner, P. V. Tishler, F. E. Speizer, and E. H. Kass. 1976. Household aggregation of pulmonary function and chronic bronchitis. Am. Rev. Respir. Dis. 114:485-492.
4. Tager, I. B., P. V. Tishler, B. Rosner, F. E. Speizer, and M. Litt. 1978. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int. J. Epidemiol. 7:55-62.
5. Higgins, M., and J. Keller. 1975. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis. 28:239-251.
6. Speizer, F. E., B. Rosner, and I. Tager. 1976. Familial aggregation of chronic respiratory disease: use of national health interview survey data for specific hypothesis testing. Int. J. Epidemiol. 5:167-172.
7. Cohen, B. H., E. L. Diamond, C. G. Graves, P. Kreiss, D. A. Levy, H. A. Menkes, S. Permutt, S. Quaskey, and M. S. Tockman. 1977. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 2:523-526.
8. Luisetti, M., and P. F. Pignatti. 1995. The search for susceptibility genes for COPD. Monaldi Arch. Chest Dis. 50:28-32.
9. Sandford, A. J., T. D. Weir, and P. D. Paré. 1997. Genetic risk factors for chronic obstructive pulmonary disease. Eur. Respir. J. 10:1380-1391.
10. Gaensslen, R. E., S. C. Bell, and H. C. Lee. 1987. Distributions of genetic markers in United States populations: III. Serum group systems and hemoglobin variants. J. Forensic Sci. 32:1754-1774.
11. Kueppers, F., R. D. Miller, H. Gordon, K. Offord, and N. G. Hepper. 1977. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am. J. Med. 63:337-342.
12. Kauffmann, F., J.-P. Kleinsbauer, A. Cambon-de-Mouzon, P. Mercier, J. Constans, M. Banc, Y. Rouch, and N. Feingold. 1983. Genetic markers in chronic airflow limitation: a genetic epidemiologic study. Am. Rev. Respir. Dis. 127:263-269.
13. Horne, S. L., D. W. Cockcroft, and J. A. Dosman. 1990. Possible protective effect against chronic obstructive airways disease by the Gc2 allele. Hum. Hered. 40:173-176.
14. Crapo, R. 1981. References spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 123:659-664.
15. Hogg, J. C, J. L. Wright, B. R. Wiggs, H. O. Coxson, A. Opazo Saez, and P. D. Paré. 1994. Long structure and function in cigarette smokers. Thorax 49:473-478.
16. Paré, P. D., and J. C. Hogg. 1995. Lung structure-function relationships. In P. Calverly and N. Pride, editors. Chronic Obstructive Pulmonary Disease. Chapman and Hall Medical, London. 34-46.
17. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Cooper, C. S., and M. R. Stratton. 1991. Extraction and enzymatic amplification of DNA from paraffin-embedded specimens. In C. Matthew, editor. Methods in Molecular Biology, Vol. 9: Protocols in Human Molecular Genetics. Humana Press, Clifton, NJ. 133-140.
19. Braun, A., A. Kofler, S. Morawietz, and H. Cleve. 1993. Sequence and organization of the human vitamin D-binding protein gene. Biochim. Biophys. Acta 1216:385-394.
20. Braun, A., R. Bichlmaier, and H. Cleve. 1992. Molecular analysis of the gene for human vitamin D binding protein (group specific component): allelic differences of the common GC types. Hum. Genet. 89:401-406.
21. Boyum, A. 1976. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immun. Suppl. 5:9-15.
22. Kew, R. R., K. W. Mollison, and R. O. Webster. 1995. Binding of Gc globulin (vitamin D binding protein) to C5a or C5a des Arg is not necessary for co-chemotactic activity. J. Leukocyte Biol 58:55-58.
23. Kew, R. R., J. A. Fisher, and R. O. Webster. 1995. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a: transient conversion into an active co-chemotaxin by neutrophils. J. Immunol 155:5369-5374.
24. Perez, H. D. 1994. Gc globulin (vitamin D binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity. Inflammation 18:215-220.
25. Piquette, C. A., R. Robinson-Hill, and R. O. Webster. 1994. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J. Leukocyte Biol 33:349-354.
26. Yamamoto, N., and S. Homma. 1991. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating factor from lysophosphatidylcholine-treated lymphocytes. Immunology 88:8539-8543.
27. Yamamoto, N., and V. Naraparaju. 1996. Role of vitamin D3-binding protein in activation of mouse macrophages. J. Immunol. 157:1744-1749.